Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Neuropharmacology. 2015 Sep 8;101:68–75. doi: 10.1016/j.neuropharm.2015.09.004

Table 2.

Effects of MDMA, 5-IT, 6-IT, and methamphetamine (METH) in the FOB. Doses (mg/kg) that produced a significant difference from vehicle are shown in columns with the corresponding average percent of vehicle shown in parenthesis. The corrected alpha level for each domain is noted in parenthesis in the first column. For comparison purposes, doses at which beam breaks were significantly increased during the second 10-min bin of the locomotor activity sessions are also shown. Only behaviors that were significantly affected by at least one drug are included.

Dependent variable MDMA 5-IT 6-IT METHa
Beam Breaks (10–20 min) 10.0 (217)
30.0 (236)
10.0 (171) 1.0 (419)
3.0 (469)
5.6 (284)
CNS Activity (α=0.0125)
Exploration 10.0 (238)
30.0 (300)
30.0 (157) 5.6 (179)
Hyperactivity 10.0 (200)
30.0 (240)
1.0 (180)
3.0 (220)
10.0 (230)
CNS Excitability (α=0.0056)
Circular Ambulations 10.0 (173)
30.0 (200)
1.0 (250)
3.0 (225)
10.0 (250)
Stereotyped Head Circling 10.0 (178) 1.0 (238)
3.0 (250)
10.0 (300)
Stereotyped Head Weaving 10.0 (250)
30.0 (275)
10.0 (142)
30.0 (150)
1.0 (175)
3.0 (175)
10.0 (263)
Stimulation 10.0 (175)
30.0 (200)
1.0 (238)
3.0 (288)
10.0 (300)
Autonomic Effects (α=0.025)
Piloerection 3.0 (150)
30.0 (220)
3.0 (160) 5.6 (174) *
Salivation 30.0 (225) 10.0 (238)
Muscle tone/Equilibrium (α=0.0125)
Flattened Body Posture 10.0 (156)
30.0 (178)
Forepaw Treading 30.0 (213) 10.0 (180) *
a

Methamphetamine data from Marusich et al. (2012).

*

Forepaw treading and piloerection were not measured in the previous study.